If they work with Peregrine in the form of interest free loan...that would be a bonus. Maybe a Grant of $100 Million from the BMGF in exchange for some shelf shares at these prices. Would prefer the interest free loan so no dilution but BMGF could certainly afford to hand over much more. I have a feeling if they were aware of the data they would certainly work with Peregrine as well. BMGF like to assist where health care is lacking....so some trial could be worked out with them.
Out of the box .. How about having a foundation sponsor behind Bavi...sort of like marketing/advertising/name recognition for the BMGF? That may not fly with a future partner but if they dont "own" Peregrine as in buyout, what would stop Peregrine from taking say $100M allowing the BMGF to become globally marketed wherever Bavi goes. If the BMGF has a marketing/advertisement budget....use that to assist Bavi...as they will gain global recognition and marketing behind what could be the future of oncology.
Out of the box agreements likr this Peregrine can do to shore up money now....and create an entirely new revenue stream never before seen in even Big Pharma.
Why would insurance company give PPHM a loan? They will pay the least they can get away with, as slowly as they can, and never more than policy limits.
News 
Market Data 
Discover 
